GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_189/2024 + UPC_CFI_434/2024

Meril Life Sciences Private Ltd. , Meril GmbH , Meril Italy S.r.l. v. Edwards Lifesciences Corporation

Date
2025-10-20
Division
Paris (FR) Central Division - Seat
Type of action
Revocation Action
Language
EN

Metadata

Case IDUPC_CFI_189-2024-UPC_CFI_434-2024-217ed6d0055d
Case number
Registry numberUPC_CFI_189/2024 + UPC_CFI_434/2024
Order reference
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 40

Central Division Paris Seat DECISION of the Court of First Instance of the Unified Patent Court Central division (Paris seat) issued on 20 October 2025 in the revocation action No. ACT_22275/2024 UPC_CFI_189/2024 and in the counterclaim for infringement No. CC_43159/2024 UPC_CFI_434/2024 HEADNOTES: 1. The assessment of the inventive step requires: first, the identification of the objective problem underlying the claimed invention, which must be carried out in light of the patent’s specification ; second, the identification of the state of the art at the time of the claimed invention, which can be represented by one or more realistic starting points and is left to the initiative of the parties ; and, finally, whether it would have been obvious for the person skilled in the art to arrive at  ...